MMP2 and autoimmune myocarditis: As we previously described, CAR reduces the contractile dysfunction of heart muscle by attenuation of MMP-2 activity and decreased degradation of troponin and myofilaments in hearts subjected to experimental autoimmune myocarditis [13].